Spectrum of focal benign musculoskeletal 18F-FDG uptake at PET/CT of the shoulder and pelvis.
OBJECTIVE
The purpose of this article is to illustrate the spectrum of common benign intraarticular and extraarticular disorders associated with focal (18)F-FDG uptake in the shoulder and pelvic areas in oncology patients referred for PET/CT.


CONCLUSIONS
A wide spectrum of benign musculoskeletal disorders associated with focal FDG uptake may be detected in cancer patients. This incidental uptake usually does not seem to be a clinically significant finding, but it can affect quality of life.
Sopov
Vladimir
V
Department of Nuclear Medicine, Rabin Medical Center, Jabotinski St., Petah Tikva, Israel.
Bernstine
Hanna
H
Stern
Dorit
D
Yefremov
Nikolay
N
Sosna
Jacob
J
Groshar
David
D
D000368:Aged; D000369:Aged, 80 and over; D003287:Contrast Media; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D007482:Iothalamate Meglumine; D008297:Male; D008875:Middle Aged; D009140:Musculoskeletal Diseases / Q000000981:diagnostic imaging*; D009369:Neoplasms / Q000473:pathology*; D010388:Pelvis; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D012782:Shoulder; D014057:Tomography, X-Ray Computed / Q000379:methods*
D003287:Contrast Media; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C001694:meglumine ioxithalamate; D007482:Iothalamate Meglumine